M Della Volpe - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Swiss Dent|September 1, 1989

[Fissure sealants]M Della Volpe

Oral-Prophylaxe|September 1, 1990

[Possibilities and limits of application of fluoride-containing varnish in caries prevention, for example, "Fluor-Protector" (2)]M Della Volpe

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 14, 1998

[Transluminal percutaneous angioplasty of stenosis of arteriovenous fistulas; 24-month follow-up]A Ortensia, G Carosio, M Iberti, et al.

British Medical Journal (Clinical Research Ed.)|November 9, 1985

Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndromeE Imbasciati, R Gusmano, A Edefonti, et al.

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2013

[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]V Saglimbene, D D'Alonzo, M Ruospo, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Swiss Dent|September 1, 1989

[Fissure sealants]M Della Volpe

Oral-Prophylaxe|September 1, 1990

[Possibilities and limits of application of fluoride-containing varnish in caries prevention, for example, "Fluor-Protector" (2)]M Della Volpe

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 14, 1998

[Transluminal percutaneous angioplasty of stenosis of arteriovenous fistulas; 24-month follow-up]A Ortensia, G Carosio, M Iberti, et al.

British Medical Journal (Clinical Research Ed.)|November 9, 1985

Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndromeE Imbasciati, R Gusmano, A Edefonti, et al.

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2013

[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]V Saglimbene, D D'Alonzo, M Ruospo, et al.

Pageof 1